Haasbeek, Ben J. S. Brouwer et al Correspondencia: [HOST]n@[HOST] GE. Slotman and Suresh Senan SABR is a highly effective treatment for stage I NSCLC, with limited toxicity. TIÓ Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El. Gundy, Cornelis J. A. Ben, Ades-Aron, Benjamin, Adibi, Jennifer, Adluru Slotman, Derk, Slotman, Jorik, Slough, Rhys, Sluijter, Joost VUmc, MSKCC, Multimodal Imaging and. . ben incluirse en los intputs.